{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:55:37Z","timestamp":1791226537315,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03223-3","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:23:30Z","timestamp":1757607810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Amorphization of Albendazole Using Organic Acid-based Solid Dispersions for Improved Dissolution: A Solvent-free Approach"],"prefix":"10.1208","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3997-354X","authenticated-orcid":false,"given":"Nilesh","family":"Jambukiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6621-1319","authenticated-orcid":false,"given":"Kiran","family":"Dudhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-8059","authenticated-orcid":false,"given":"Sunny","family":"shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9517-7578","authenticated-orcid":false,"given":"Chetan","family":"Borkhataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7075-9237","authenticated-orcid":false,"given":"Trupesh","family":"Pethani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2111-7068","authenticated-orcid":false,"given":"Ramesh","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8606-3466","authenticated-orcid":false,"given":"Viral","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-0018","authenticated-orcid":false,"given":"Gaurav","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7378-1651","authenticated-orcid":false,"given":"Mori","family":"Dhaval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"2\u20133","key":"3223_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0001-706X(03)00031-7","volume":"86","author":"AD Dayan","year":"2003","unstructured":"Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica. 2003;86(2\u20133):141\u201359.","journal-title":"Acta Tropica"},{"issue":"3","key":"3223_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3347\/kjp.2021.59.3.189","volume":"59","author":"J-Y Chai","year":"2021","unstructured":"Chai J-Y, Jung B-K, Hong S-J. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: an update. Korean J Parasitol. 2021;59(3):189.","journal-title":"Korean J Parasitol"},{"issue":"S1","key":"3223_CR3","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1017\/S0031182000007290","volume":"121","author":"J Horton","year":"2000","unstructured":"Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121(S1):S113\u201332.","journal-title":"Parasitology"},{"key":"3223_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2022.108355","volume":"242","author":"J Jacob","year":"2022","unstructured":"Jacob J, Siraj MA, Steel A, Tan G, Jarvi S. Evaluation of the mechanism of action of albendazole on adult rat lungworm (Angiostrongylus\ncantonensis). Exp Parasitol. 2022;242: 108355.","journal-title":"Exp Parasitol"},{"key":"3223_CR5","first-page":"457","volume-title":"Side Effects of Drugs Annual","author":"R Reich","year":"2014","unstructured":"Reich R, Mulvaney P, Robinson-Bostom L. Chapter 31 - Antihelminthic Drugs. In: Ray SD, editor. Side Effects of Drugs Annual. Elsevier; 2014. p. 457\u201364."},{"key":"3223_CR6","unstructured":"World Health O. The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2023 (including the 23rd WHO Model List of Essential Medicines and the 9th WHO Model List of Essential Medicines for Children). Technical Report Series - World Health Organization. World Health Organization; 2024."},{"issue":"1","key":"3223_CR7","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-022-02497-1","volume":"24","author":"L Liu","year":"2023","unstructured":"Liu L, Nie J, Li L. Phospholipid complexation for bioavailability improvement of Albendazole: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 2023;24(1): 36.","journal-title":"AAPS PharmSciTech"},{"key":"3223_CR8","doi-asserted-by":"publisher","first-page":"125142","DOI":"10.1016\/j.molliq.2024.125142","volume":"406","author":"S Tang","year":"2024","unstructured":"Tang S, Guo Z, Liu J, Nie K, Hu C. Albendazole oral drug delivery through ASBT-mediated cholic acid derivatives: A win-win for solubility and permeability. J Mol Liq. 2024;406:125142.","journal-title":"J Mol Liq"},{"issue":"6","key":"3223_CR9","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.xphs.2021.11.010","volume":"111","author":"JB Eriksen","year":"2022","unstructured":"Eriksen JB, Christensen SB, Bauer-Brandl A, Brandl M. Dissolution\/permeation of Albendazole in the presence of cyclodextrin and bile salts: a mechanistic in vitro study into factors governing oral bioavailability. J Pharm Sci. 2022;111(6):1667\u201373. https:\/\/doi.org\/10.1016\/j.xphs.2021.11.010.","journal-title":"J Pharm Sci"},{"issue":"12","key":"3223_CR10","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1021\/acs.molpharmaceut.9b00851","volume":"16","author":"C Hu","year":"2019","unstructured":"Hu C, Liu Z, Liu C, Li J, Wang Z, Xu L, et al. Enhanced oral bioavailability and anti-echinococcosis efficacy of albendazole achieved by optimizing the \u201cspring\u201d and \u201cparachute.\u201d Mol Pharm. 2019;16(12):4978\u201386.","journal-title":"Mol Pharm"},{"issue":"5","key":"3223_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1021\/acsinfecdis.9b00231","volume":"6","author":"C Hu","year":"2019","unstructured":"Hu C, Liu Z, Liu C, Zhang Y, Fan H, Qian F. Improvement of antialveolar echinococcosis efficacy of albendazole by a novel nanocrystalline formulation with enhanced oral bioavailability. ACS Infect Dis. 2019;6(5):802\u201310.","journal-title":"ACS Infect Dis"},{"key":"3223_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105552","volume":"155","author":"M Pettarin","year":"2020","unstructured":"Pettarin M, Bolger MB, Chronowska M, Kostewicz ES. A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS class II\/IV weak base albendazole and its main metabolite albendazole sulfoxide. Eur J Pharm Sci. 2020;155: 105552.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"3223_CR13","first-page":"63","volume":"75","author":"FK Alanazi","year":"2007","unstructured":"Alanazi FK, El-Badry M, Ahmed MO, Alsarra IA. Improvement of albendazole dissolution by preparing microparticles using spray-drying technique. Scient Pharm. 2007;75(2):63\u201380.","journal-title":"Scient Pharm"},{"issue":"9","key":"3223_CR14","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1039\/C5CE02306H","volume":"18","author":"A Thakur","year":"2016","unstructured":"Thakur A, Thipparaboina R, Kumar D, Gouthami KS, Shastri NR. Crystal engineered albendazole with improved dissolution and material attributes. CrystEngComm. 2016;18(9):1489\u201394.","journal-title":"CrystEngComm"},{"issue":"1\u20132","key":"3223_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijpharm.2016.01.006","volume":"499","author":"L Martinez-Marcos","year":"2016","unstructured":"Martinez-Marcos L, Lamprou DA, McBurney RT, Halbert GW. A novel hot-melt extrusion formulation of albendazole for increasing dissolution properties. Int J Pharm. 2016;499(1\u20132):175\u201385.","journal-title":"Int J Pharm"},{"issue":"4","key":"3223_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2478\/v10007-012-0031-0","volume":"62","author":"AK Meena","year":"2012","unstructured":"Meena AK, Sharma K, Kandaswamy M, Rajagopal S, Mullangi R. Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure. Acta Pharm. 2012;62(4):563\u201380.","journal-title":"Acta Pharm"},{"key":"3223_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124548","volume":"663","author":"MI Syed","year":"2024","unstructured":"Syed MI, Kandagatla HP, Avdeef A, Serajuddin ATM. Supersolubilization and amorphization of a weakly acidic drug, Flurbiprofen, by applying acid-base supersolubilization (ABS) principle. Int J Pharm. 2024;663: 124548. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124548.","journal-title":"Int J Pharm"},{"key":"3223_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104852","volume":"88","author":"Y Guo","year":"2023","unstructured":"Guo Y, Patel H, Saraswat A, Mateti KV, Patel K, Squillante E. Screening and optimization of supercritical fluid process for the preparation of albendazole solid dispersion. J Drug Deliv Sci Technol. 2023;88: 104852.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3223_CR19","doi-asserted-by":"publisher","first-page":"106751","DOI":"10.1016\/j.ejps.2024.106751","volume":"196","author":"M-J Han","year":"2024","unstructured":"Han M-J, Zou ZZ. Enabling a novel solvent method on Albendazole solid dispersion to improve the in vivo bioavailability. Eur J Pharm Sci. 2024;196:106751. https:\/\/doi.org\/10.1016\/j.ejps.2024.106751.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"3223_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12247-020-09520-7","volume":"17","author":"M Dhaval","year":"2022","unstructured":"Dhaval M, Sharma S, Dudhat K, Chavda J. Twin-screw extruder in pharmaceutical industry: history, working principle, applications, and marketed products: an in-depth review. J Pharm Innov. 2022;17(2):294\u2013318. https:\/\/doi.org\/10.1007\/s12247-020-09520-7.","journal-title":"J Pharm Innov"},{"key":"3223_CR21","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s11095-009-9852-z","volume":"26","author":"W Curatolo","year":"2009","unstructured":"Curatolo W, Nightingale JA, Herbig SM. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res. 2009;26:1419\u201331.","journal-title":"Pharm Res"},{"issue":"4","key":"3223_CR22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.xphs.2018.10.058","volume":"108","author":"NG Solanki","year":"2019","unstructured":"Solanki NG, Lam K, Tahsin M, Gumaste SG, Shah AV, Serajuddin ATM. Effects of surfactants on itraconazole-HPMCAS solid dispersion prepared by hot-melt extrusion I: miscibility and drug release. J Pharm Sci. 2019;108(4):1453\u201365.","journal-title":"J Pharm Sci"},{"issue":"10","key":"3223_CR23","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1021\/js980403l","volume":"88","author":"ATM Serajuddin","year":"1999","unstructured":"Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88(10):1058\u201366.","journal-title":"J Pharm Sci"},{"key":"3223_CR24","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s11095-013-0994-7","volume":"30","author":"S Singh","year":"2013","unstructured":"Singh S, Parikh T, Sandhu HK, Shah NH, Malick AW, Singhal D, et al. Supersolubilization and amorphization of a model basic drug, haloperidol, by interaction with weak acids. Pharm Res. 2013;30:1561\u201373.","journal-title":"Pharm Res"},{"issue":"4","key":"3223_CR25","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03084-w","volume":"26","author":"A Gadoya","year":"2025","unstructured":"Gadoya A, Dudhat K, Shah S, Borkhataria C, Pethani T, Shah V, et al. Amorphous solid dispersion\/salt of Efavirenz: investigating the role of molecular interactions on recrystallization and in-vitro dissolution performance. AAPS PharmSciTech. 2025;26(4): 89. https:\/\/doi.org\/10.1208\/s12249-025-03084-w.","journal-title":"AAPS PharmSciTech"},{"key":"3223_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140808","volume":"1323","author":"Q He","year":"2025","unstructured":"He Q, Xiang T, Liu S, Sun CC. Preparation and solid-state characterization of two novel berberine chloride cocrystals with benzene derivatives. J Mol Struct. 2025;1323: 140808. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140808.","journal-title":"J Mol Struct"},{"key":"3223_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120524","volume":"600","author":"NG Patel","year":"2021","unstructured":"Patel NG, Serajuddin ATM. Development of FDM 3D-printed tablets with rapid drug release, high drug-polymer miscibility and reduced printing temperature by applying the acid-base supersolubilization (ABS) principle. Int J Pharm. 2021;600: 120524.","journal-title":"Int J Pharm"},{"key":"3223_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/B978-0-12-814399-5.00002-5","volume-title":"Red Wine Technology","author":"P Comuzzo","year":"2019","unstructured":"Comuzzo P, Battistutta F. Chapter 2 - Acidification and pH Control in Red Wines. In: Morata A, editor. Red Wine Technology. Academic Press; 2019. p. 17\u201334."},{"key":"3223_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/B978-0-444-63453-5.00005-7","volume-title":"Industrial Biorefineries & White Biotechnology","author":"R H\u00f6fer","year":"2015","unstructured":"H\u00f6fer R. Chapter 4A - Sugar- and Starch-Based Biorefineries. In: Pandey A, H\u00f6fer R, Taherzadeh M, Nampoothiri KM, Larroche C, editors. Industrial Biorefineries & White Biotechnology. Amsterdam: Elsevier; 2015. p. 157\u2013235."},{"issue":"4","key":"3223_CR30","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12247-021-09588-9","volume":"17","author":"M Patel","year":"2022","unstructured":"Patel M, Mori D, Dudhat K, Shah S, Chavda J, Patel A. Saturation Solubility and Dissolution Property Improvement of Albendazole by Salt Formation Approach. Journal of Pharmaceutical Innovation. 2022;17(4):1148\u201359. https:\/\/doi.org\/10.1007\/s12247-021-09588-9.","journal-title":"Journal of Pharmaceutical Innovation."},{"issue":"1\u20132","key":"3223_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.07.037","volume":"419","author":"N Qiao","year":"2011","unstructured":"Qiao N, Li M, Schlindwein W, Malek N, Davies A, Trappitt G. Pharmaceutical cocrystals: an overview. Int J Pharm. 2011;419(1\u20132):1\u201311.","journal-title":"Int J Pharm"},{"issue":"13","key":"3223_CR32","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1021\/acs.chemrev.1c00987","volume":"122","author":"G Bolla","year":"2022","unstructured":"Bolla G, Sarma B, Nangia AK. Crystal engineering of pharmaceutical cocrystals in the discovery and development of improved drugs. Chem Rev. 2022;122(13):11514\u2013603.","journal-title":"Chem Rev"},{"issue":"2","key":"3223_CR33","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1021\/acs.cgd.0c01444","volume":"21","author":"PD Carvalho Jr","year":"2021","unstructured":"Carvalho PD Jr, Diniz LF, da Silva GT, Coutinho ND, dos Santos PG, Carvalho-Silva VH, et al. Amino\u2013imino tautomerism in the salt formation of albendazole: hydrobromide and nitrate salts. Cryst Growth Des. 2021;21(2):1122\u201335.","journal-title":"Cryst Growth Des"},{"key":"3223_CR34","doi-asserted-by":"publisher","unstructured":"Hu C, Zhong X, Li C, Yan H. Supersaturated drug delivery system of albendazole salt-polymer complex for improving oral bioavailability and efficacy anti-secondary E.\nmultilocularis. Acta Trop. 2024;260: 107464. https:\/\/doi.org\/10.1016\/j.actatropica.2024.107464.","DOI":"10.1016\/j.actatropica.2024.107464"},{"issue":"8","key":"3223_CR35","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1021\/acs.cgd.9b00348","volume":"19","author":"A Bongioanni","year":"2019","unstructured":"Bongioanni A, Bueno MS, Abraham-Miranda J, Chattah AK, Ayala AP, Longhi MR, et al. Investigating a soluble pharmaceutical salt: albendazole hydrochloride. Cryst Growth Des. 2019;19(8):4538\u201345.","journal-title":"Cryst Growth Des"},{"issue":"3","key":"3223_CR36","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1021\/acs.molpharmaceut.7b00932","volume":"15","author":"MH Fung","year":"2018","unstructured":"Fung MH, DeVault M, Kuwata KT, Suryanarayanan R. Drug-excipient interactions: effect on molecular mobility and physical stability of ketoconazole\u2013organic acid coamorphous systems. Mol Pharm. 2018;15(3):1052\u201361.","journal-title":"Mol Pharm"},{"issue":"8","key":"3223_CR37","first-page":"6310","volume":"20","author":"S Gunasekaran","year":"2008","unstructured":"Gunasekaran S, Uthra D. Vibrational spectra and qualitative analysis of albendazole and mebendazole. Asian J Chem. 2008;20(8):6310.","journal-title":"Asian J Chem"},{"issue":"3","key":"3223_CR38","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.ejpb.2013.03.014","volume":"85","author":"K L\u00f6bmann","year":"2013","unstructured":"L\u00f6bmann K, Grohganz H, Laitinen R, Strachan C, Rades T. Amino acids as co-amorphous stabilizers for poorly water soluble drugs\u2013part 1: preparation, stability and dissolution enhancement. Eur J Pharm Biopharm. 2013;85(3):873\u201381.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3223_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijpharm.2017.09.063","volume":"533","author":"G Kasten","year":"2017","unstructured":"Kasten G, Nouri K, Grohganz H, Rades T, L\u00f6bmann K. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine. Int J Pharm. 2017;533(1):138\u201344. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.063.","journal-title":"Int J Pharm"},{"issue":"3","key":"3223_CR40","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ejpb.2013.03.026","volume":"85","author":"K L\u00f6bmann","year":"2013","unstructured":"L\u00f6bmann K, Laitinen R, Strachan C, Rades T, Grohganz H. Amino acids as co-amorphous stabilizers for poorly water-soluble drugs\u2013part 2: molecular interactions. Eur J Pharm Biopharm. 2013;85(3):882\u20138.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"3223_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/jphp.12458","volume":"68","author":"KT Jensen","year":"2016","unstructured":"Jensen KT, Blaabjerg LI, Lenz E, Bohr A, Grohganz H, Kleinebudde P, et al. Preparation and characterization of spray-dried co-amorphous drug\u2013amino acid salts. J Pharm Pharmacol. 2016;68(5):615\u201324.","journal-title":"J Pharm Pharmacol"},{"key":"3223_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejpb.2015.07.011","volume":"96","author":"E Lenz","year":"2015","unstructured":"Lenz E, Jensen KT, Blaabjerg LI, Knop K, Grohganz H, L\u00f6bmann K, et al. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin\u2013arginine. Eur J Pharm Biopharm. 2015;96:44\u201352.","journal-title":"Eur J Pharm Biopharm"},{"key":"3223_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejpb.2016.11.023","volume":"112","author":"R Ojarinta","year":"2017","unstructured":"Ojarinta R, Heikkinen AT, Siev\u00e4nen E, Laitinen R. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: the ability of amino acids to stabilize the supersaturated state of indomethacin. Eur J Pharm Biopharm. 2017;112:85\u201395.","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"3223_CR44","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.3109\/10717544.2016.1153746","volume":"23","author":"EM Maher","year":"2016","unstructured":"Maher EM, Ali AMA, Salem HF, Abdelrahman AA. In vitro\/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids. Drug Deliv. 2016;23(8):3088\u2013100.","journal-title":"Drug Deliv"},{"issue":"6","key":"3223_CR45","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s11095-016-1890-8","volume":"33","author":"T Parikh","year":"2016","unstructured":"Parikh T, Sandhu HK, Talele TT, Serajuddin ATM. Characterization of solid dispersion of itraconazole prepared by solubilization in concentrated aqueous solutions of weak organic acids and drying. Pharm Res. 2016;33(6):1456\u201371.","journal-title":"Pharm Res"},{"key":"3223_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.saa.2012.02.026","volume":"92","author":"K Ganesh","year":"2012","unstructured":"Ganesh K, Balraj C, Satheshkumar A, Elango KP. Spectroscopic investigation on the mechanism of formation of molecular complexes of albendazole and trimethoprim with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. Spectrochim Acta A Mol Biomol Spectrosc. 2012;92:46\u201355. https:\/\/doi.org\/10.1016\/j.saa.2012.02.026.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"3223_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101875","volume":"59","author":"X Shi","year":"2020","unstructured":"Shi X, Fan B, Gu C, Zhou X, Wang C, Ding Z. Ibrutinib and carboxylic acid coamorphous system with increased solubility and dissolution: a potential interaction mechanism. J Drug Deliv Sci Technol. 2020;59: 101875.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3, Part B","key":"3223_CR48","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ejpb.2013.03.026","volume":"85","author":"K L\u00f6bmann","year":"2013","unstructured":"L\u00f6bmann K, Laitinen R, Strachan C, Rades T, Grohganz H. Amino acids as co-amorphous stabilizers for poorly water-soluble drugs \u2013 Part 2: Molecular interactions. Eur J Pharm Biopharm. 2013;85(3, Part B):882\u20138. https:\/\/doi.org\/10.1016\/j.ejpb.2013.03.026.","journal-title":"Eur J Pharm Biopharm"},{"key":"3223_CR49","doi-asserted-by":"publisher","first-page":"119741","DOI":"10.1016\/j.ijpharm.2020.119741","volume":"588","author":"GC Bazzo","year":"2020","unstructured":"Bazzo GC, Pezzini BR, Stulzer HK. Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs. Int J Pharm. 2020;588:119741.","journal-title":"Int J Pharm"},{"key":"3223_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtcomm.2023.107411","volume":"37","author":"M Dhaval","year":"2023","unstructured":"Dhaval M, Dudhat K, Soniwala M, Dudhrejiya A, shah S, Prajapati B. A review on stabilization mechanism of amorphous form based drug delivery system. Mater Today Commun. 2023;37: 107411. https:\/\/doi.org\/10.1016\/j.mtcomm.2023.107411.","journal-title":"Mater Today Commun"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03223-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03223-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03223-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T14:53:16Z","timestamp":1758725596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03223-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3223"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03223-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No human subjects or animals were used during this research work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"228"}}